Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells
- PMID: 12680256
Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells
Abstract
SiHa cervical squamous carcinoma cells were resistant to ATRA-induced growth inhibitory effect at a physiological dose (10(-6) M), but responsive at a pharmacological dose (10(-4) M). The observed growth arrest was associated with increased levels of the interferon regulatory factor-1 (IRF-1). IRF-1 is a known inhibitor of cell growth, and thus our aim was to identify the downstream target of this growth inhibitory function. We found that, as with the induction of IRF-1, levels of p21WAF1 were similarly dose-dependently induced by ATRA. Semiquantitative RT-PCR, Western blotting, gel-shift analysis (EMSA), antisense gene expression and application of a STAT1-knockout cell line demonstrated that activation of the p21WAF1 gene was IRF-1 and STAT1-dependent. We concluded that activation of STAT1 and IRF-1 is crucial for the growth inhibitory action of ATRA, which is associated with the activation of p21WAF1. These results might be useful in chemoprevention of cervical cancers.
Similar articles
-
All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells.Anticancer Res. 2003 Jan-Feb;23(1A):471-3. Anticancer Res. 2003. PMID: 12680251
-
Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.Clin Diagn Lab Immunol. 2002 Sep;9(5):1102-6. doi: 10.1128/cdli.9.5.1102-1106.2002. Clin Diagn Lab Immunol. 2002. PMID: 12204966 Free PMC article.
-
Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.Oncogene. 1997 Sep 18;15(12):1425-35. doi: 10.1038/sj.onc.1201318. Oncogene. 1997. PMID: 9333018
-
Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.Cancer Res. 2004 Jun 15;64(12):4155-61. doi: 10.1158/0008-5472.CAN-03-2750. Cancer Res. 2004. PMID: 15205326
-
MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.Anticancer Res. 1997 Jul-Aug;17(4A):2627-33. Anticancer Res. 1997. PMID: 9252692
Cited by
-
Expression and DNA binding activity of the recombinant interferon regulatory factor-1 (IRF-1) of mouse.Mol Biol Rep. 2005 Jun;32(2):103-16. doi: 10.1007/s11033-004-6940-3. Mol Biol Rep. 2005. PMID: 16022283
-
Retinoids: Molecular Aspects and Treatment in Premalignant Lesions and Cervical Cancer.Cancer Control. 2024 Jan-Dec;31:10732748241279514. doi: 10.1177/10732748241279514. Cancer Control. 2024. PMID: 39163121 Free PMC article. Review.
-
Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.Br J Pharmacol. 2012 Sep;167(2):279-97. doi: 10.1111/j.1476-5381.2012.02002.x. Br J Pharmacol. 2012. PMID: 22536923 Free PMC article. Review.
-
Identification and characterization of the human NOL7 gene promoter.Gene. 2010 May 15;456(1-2):36-44. doi: 10.1016/j.gene.2010.02.008. Epub 2010 Mar 3. Gene. 2010. PMID: 20206243 Free PMC article.
-
Manipulation of Epithelial Differentiation by HPV Oncoproteins.Viruses. 2019 Apr 22;11(4):369. doi: 10.3390/v11040369. Viruses. 2019. PMID: 31013597 Free PMC article. Review.